SCHEMBL19697958

SCHEMBL19697958

CC1CC(n2ncc3ccc(C(C)C)cc32)CC(C)O1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ PIK3CD O00329 7/20 0.42
▸ LRRK2 Q5S007 3/20 0.35
▸ ALDH1A1 P00352 1/20 0.34
▸ TLR9 Q9NR96 1/20 0.33
▸ TLR8 Q9NR97 1/20 0.33
▸ TLR7 Q9NYK1 1/20 0.33
▸ KDM5A P29375 1/20 0.33
▸ HTR1A P08908 1/20 0.32
▸ HTR1B P28222 1/20 0.32
▸ HTR1F P30939 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ NPC1 O15118 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ SCD O00767 2/20 0.31
▸ PDE9A O76083 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19701294 0.89 PIK3CD (0.39) PIK3CDMAPK1
SCHEMBL22357767 0.83 HTR1A (0.40) PIK3CDKDM5AHTR1AHTR1BHTR1F
SCHEMBL21251097 0.82 PIK3CD (0.43) PIK3CDLRRK2ALDH1A1HTR1AHTR1B
SCHEMBL20676266 0.82 PIK3CD (0.36) PIK3CDKDM5AHTR1AHTR1BHTR1F
SCHEMBL19689422 0.81 PIK3CD (0.43) PIK3CDLRRK2ALDH1A1HTR1AHTR1B
SCHEMBL22357772 0.81 PDE9A (0.42) PIK3CDKDM5AHTR1AHTR1BHTR1F
SCHEMBL19698032 0.80 MAPK1 (0.47) PIK3CDMAPK1
SCHEMBL26997309 0.80 KDM5A (0.39) PIK3CDKDM5AHTR1AHTR1BHTR1F
SCHEMBL19697984 0.80 PDE9A (0.44) PIK3CDHTR1AHTR1BHTR1FMAPK1
SCHEMBL19701296 0.79 PIK3CD (0.42) PIK3CDLRRK2HTR1AHTR1BHTR1F

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10023576-B2 Heteroaryl substituted pyrrolotriazine amine compounds as PI3K inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2018-07-17 — — US disclosed
US-20170355698-A1 HETEROARYL SUBSTITUTED PYRROLOTRIAZINE AMINE COMPOUNDS AS PI3K INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2017-12-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10023576-B2 Heteroaryl substituted pyrrolotriazine amine compounds as PI3K inhibitors PIK3R3, PIK3R5, PIK3R1 PIK3CD 6/4885LRRK2 448/4885ALDH1A1 4203/4885
US-20170355698-A1 HETEROARYL SUBSTITUTED PYRROLOTRIAZINE AMINE COMPOUNDS AS PI3K INHIBITORS PIK3R3, PIK3R5, PIK3R1 PIK3CD 6/4885LRRK2 448/4885ALDH1A1 4203/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback